MILY NGUYEN: Open Payments
NPI 1427328566 · ALBUQUERQUE, NM. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$547 in 10 payments from 6 companies in 2025. Trend: 2023 $336 · 2024 $201 · 2025 $547
Food & beverage: $497Education: $50
| Company | Payments | Amount |
|---|---|---|
| ABIOMED | 3 | $179 |
| Amgen Inc. | 1 | $117 |
| AstraZeneca Pharmaceuticals LP | 1 | $112 |
| Chiesi USA, Inc. | 3 | $95 |
| Novartis Pharmaceuticals Corporation | 1 | $22 |
| E.R. Squibb & Sons, L.L.C. | 1 | $22 |
Products named: REPATHA, LOKELMA, CLEVIPREX, KENGREAL, LEQVIO, ELIQUIS.
Industry payments across NM — which companies pay providers there.
